Related Experiment Video
Updated: Jan 14, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
560
Building Pediatric Hematology/Oncology Workforce Capacity in Latin America
Daniel C Moreira1, Federico Antillón-Klussmann2,3, Roy Rosado2
1St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatric Blood & Cancer
|October 23, 2025
Summary
Five Latin American pediatric hematology/oncology programs successfully train specialists. Graduates integrate well into the workforce, contributing to regional pediatric cancer care and leadership roles.
Area of Science:
- Medical Education
- Pediatric Oncology
- Global Health Workforce Development
Background:
- Assessing the impact of five pediatric hematology/oncology fellowship programs in Latin America.
- Analyzing trainee and graduate profiles and their workforce integration.
Purpose of the Study:
- To evaluate the effectiveness of St. Jude Global Academy's collaborative fellowship programs in Latin America.
- To understand the career trajectories and contributions of trained pediatric hematologists/oncologists.
Main Methods:
- Collaboration with five key institutions across Latin America (Guatemala, Mexico, Uruguay, Brazil).
- Data collection on trainee origin, completion rates, and graduate employment.
- Surveying graduates regarding current roles, responsibilities, and time allocation.
Main Results:
- 110 physicians from 14 countries trained; 61.8% completed programs.
- 79.7% of respondents work in pediatric cancer units, with 62.7% starting immediately post-training.
- Graduates dedicate significant time to pediatric oncology (52.0%) and many hold leadership positions (44%).
Conclusions:
- The fellowship programs effectively train specialists for pediatric cancer care in Latin America.
- Graduates demonstrate high workforce integration and regional contribution.
- Further research is needed for a comprehensive regional workforce strategy.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
01:28Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
01:19Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
01:28International Nursing Organizations II
1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
01:21Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K